№2(7) 2024

DOI 10.37219/2528-8253-2024-2-2

Ostrovska D, Dieieva Yu

POSTOPERATIVE COURSE IN PATIENTS WITH CHRONIC RHINOSINUSITIS

Ostrovska Daria A
Bogomolets National Medical University, Kyiv, Ukraine
Postgraduate student of the Department of Otorhinolaryngology
Email: dr.ostrovskaya.d@gmail.com
ORCID: https://orcid.org/0009-0002-5983-6323
 
Dieieva Julia V
Bogomolets National Medical University, Kyiv, Ukraine
Head of the department of Otorhinolaryngology
MD, PhD, professor
Email: deyeva@bigmir.net
ORCID ID: https://orcid.org/0000-0003-0552-1254
https://www.scopus.com/authid/detail.uri?authorId=55359076200

Abstract

Relevance: All phenotypes of chronic rhinosinusitis (CRS) are characterized by concurrent inflammatory and remodelling processes, the activity of which depends on various factors, including atopic status. It is believed that these processes are more pronounced in CRS with nasal polyposis (CRSwNP), while they are significantly less pronounced in CRS without nasal polyposis (CRSsNP). Considering this, we hypothesized that the recovery of the nasal mucosa after functional endoscopic sinus surgery in patients with CRS may depend on the disease phenotype and will be slower, resulting in higher symptom severity in patients.

Objective: To compare the histopathological picture of postoperative material and the postoperative course in patients with different phenotypes of CRS (CRSwNP and CRSsNP).

Materials and Methods: The study included 87 patients in the main group and 12 patients in the control group. Patients in the main group were divided into 2 subgroups, depending on the phenotype of CRS – CRSwNP (n=38) and CRSsNP (cyst of the maxillary sinuses) (n=49). All patients were surveyed using the NOSE questionnaire on the 3rd, 7th, and 14th days after the postoperative period. Additionally, the frequency of ciliary beatings was evaluated in patients included in the study on the 7th and 14th days after the postoperative period. Postoperative material was examined by a pathomorphologist.

Results: In the postoperative period on the 7th day, for the control group after septoplasty and bilateral ethmoidectomy, the ciliary beat frequency (CBF) reached 4.12±0.53 Hz, for subgroup A (CRSwNP) – 3.53±0.57 Hz, and for subgroup B – 3.82±0.41 Hz. On the 14th day, the mean CBF values for the control group were 5.98±0.36 Hz, for subgroup A – 5.08±0.72 Hz, and for subgroup B – 5.7±0.43 Hz. Regarding the NOSE scale, on the 7th postoperative day, the average scores for the groups were as follows: control – 70.4, subgroup A – 82.6, subgroup B – 70.4. On the 14th day, the results were better: Control group – 11.6, subgroup A – 18.5, subgroup B – 15.95 points. Additionally, we found a positive correlation between CBF and NOSE scale values.

Conclusions: The rate of nasal mucosa recovery, its structural units, is higher in patients with less pronounced remodelling processes. Thus, the function of the ciliated epithelium, its cilia, after surgical treatment was higher on each of the studied days in the control group and subgroup B (CRSsNP). The presence of a higher severity of nasal congestion symptom in the postoperative period according to the NOSE scale is more characteristic of CRSwNP. Additionally, an association of this scale with the ciliary beat frequency was found – a lower NOSE scale score corresponds to a higher ciliary beat frequency.

Keywords: chronic rhinosinusitis, nasal polyps, tissue remodelling, surgical treatment, postoperative period, nasal cavity mucosa, pathohistological study, ciliated epithelium, ciliary beat frequency, matrix metalloproteinase.

References

  1. George SJ, Dwivedi A. MMPs, cadherins, and cell proliferation. Trends Cardiovasc Med. 2004 Apr; 14(3):100-5. doi: 10.1016/j.tcm.2003.12.008.
  2. Vignola A, Riccobono L, Mirabella A, Profita M, Chanez P, Bellia V, et al. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med. 1998 Dec;158(6):1945-50. doi: 10.1164/ajrccm.158.6.9803014.
  3. Radajewski K, Wierzchowska M, Grzanka D, Antosik P, Zdrenka M, Burduk P. Tissue remodelling in chronic rhinosinusitis – review of literature. Otolaryngol Pol. 2019 Sep 2;73(5):1-4. doi: 10. 5604/01.3001.0013.4121.
  4. Lee HY, Pyo JS, Kim SJ. Distinct patterns of tissue remodeling and their prognostic role in chronic rhinosinusitis. ORL J Otorhinolaryngol Relat Spec. 2021;83(6):457-463. doi: 10.1159/000515005.
  5. Lucas BR, Voegels RL, do Amaral JB, Bachi ALL, Pezato R. BMP-7, MMP-9, and TGF-β tissue remodeling proteins and their correlations with interleukins 6 and 10 in chronic rhinosinusitis. Eur Arch Otorhinolaryngol. 2021 Nov;278(11):4335-4343. doi: 10.1007/s00405-021-06722-8.
  6. Watelet JB, Dogne JM, Mullier F. Remodeling and Repair in Rhinosinusitis. Curr Allergy Asthma Rep. 2015;15(6):34. doi: 10.1007/s11882-015-0531-3.
  7. Lee YS, Olefsky J. Chronic tissue inflammation and metabolic disease. Genes Dev. 2021 Mar 1;35 (5-6):307-328. doi: 10.1101/gad.346312.120.
  8. Nhu QM, Aceves SS. Tissue remodeling in chronic eosinophilic esophageal inflammation: parallels in asthma and therapeutic perspectives. Front Med (Lausanne). 2017 Aug 7:4:128. doi: 10.3389/fmed.2017.00128.
  9. Wang LF, Chien CY, Chiang FY, Chai CY, Tai CF. Corelationship between matrix metalloproteinase 2 and 9 expression and severity of chronic rhinosinusitis with nasal polyposis. Am J Rhinol Allergy. 2012 Jan-Feb;26(1):e1-4. doi: 10.2500/ajra.2012.26.3724.
  10. Siddiqui S, Bachert C, Bjermer L, Buchheit KM, Castro M, Qin Y, et al. Eosinophils and tissue remodeling: relevance to airway disease. J Allergy Clin Immunol. 2023 Oct;152(4):841-857. doi: 10.1016/j.jaci.2023.06.005.
  11. Hargas L, Koniar D, Stofan S. Advanced methodology for frequency description of biomechanical systems. Procedia Eng. 2012;48:205‐212.
  12. Liu J, Khalil RA. Matrix metalloproteinase inhibitors as investigational and therapeutic tools in unrestrained tissue remodeling and pathological disorders. Prog Mol Biol Transl Sci. 2017:148:355-420. doi: 10.1016/bs.pmbts.2017.04.003.
  13. Piperigkou Z, Kyriakopoulou K, Koutsakis C, Mastronikolis S, Karamanos NK. Key matrix remodeling enzymes: functions and targeting in cancer. Cancers (Basel). 2021 Mar 22;13(6):1441. doi: 10.3390/cancers13061441.
  14. Kuo CHS, Pavlidis S, Zhu J, Loza M, Baribaud F, Rowe A, et al. Contribution of airway eosinophils in airway wall remodeling in asthma: role of MMP‐10 and MET. Allergy. 2019 Jun;74(6):1102-1112. doi: 10.1111/all.13727.
  15. Kostamo K, Tervahartiala T, Sorsa T, Richardson M, Toskala E. Metalloproteinase function in chronic rhinosinusitis with nasal polyposis. Laryngoscope. 2007 Apr;117(4):638-43. doi: 10.1097/ MLG.0b013e318030aca6.
  16. Ostrovska DA. [Remodelling of nasal mucosa depending on the phenotype of chronic rhinosinusitis and endoprotease expression]. Otorhinolaryngology. 2024;7(1):22-31. doi: 10.37219/2528-8253-2024-1-22. [Article in Ukrainian].  
  17. Xiang R, Zhang Qp, Zhang W, Kong Y-G, Tan L, Chen S-M,  et al. Different effects of allergic rhinitis on nasal mucosa remodeling in chronic rhinosinusitis with and without nasal polyps. Eur Arch Otorhinolaryngol. 2019 Jan;276(1):115-130. doi: 10.1007/s00405-018-5195-x.
  18. Katainen E, Kostamo K, Virkkula P, Sorsa T, Tervahartiala T, Haapaniemi A, Toskala E. Local and systemic proteolytic responses in chronic rhinosinusitis with nasal polyposis and asthma. Int Forum Allergy Rhinol. 2015 Apr;5(4):294-302. doi: 10.1002/alr.21486.
  19. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. Executive summary of EPOS 2020 including integrated care pathways. Rhinology. 2020 Apr 1;58(2):82-111. doi: 10.4193/Rhin20.601.